Medical device maker Boston Scientific said on Monday it agreed to sell its cardiac surgery and vascular surgery businesses to Sweden's Getinge Group for $750 million.
Boston Scientific also said the deal with the Swedish medical equipment company is expected to close within the next 45 to 90 days.
"The price seems fair, and this suits Getinge very well since they want to grow in the U.S. Our first impression is that this was expected in the market, but it's still very positive," said Swedbank analyst Johan Unnerus.
"We expect a positive (Getinge share) reaction. (Getinge) has a history of finding and carrying through acquisitions and I also don't think the price is seen as high."
Getinge's shares rose 1.7 percent in early trade on Monday.
Last month, Boston Scientific announced plans to reduce its work force by about 9 percent and restructure or sell several business units in an effort to reduce operating expenses.
Boston Scientific has been hurt recently by a drop in sales of implantable heart devices.